Le Lézard
Classified in: Health
Subjects: NPT, CSR

Good Samaritan Hospital Receives $21 Million Gift from Charles T. Munger


LOS ANGELES, March 8, 2018 /PRNewswire-USNewswire/ -- Good Samaritan Hospital received a $21 million gift from Charles T. Munger, vice chairman of Berkshire Hathaway.  Mr. Munger has served as chairman of the board of trustees at Good Samaritan Hospital for the past 31 years.  The gift will support the emergency department expansion project and address seismic improvements to the hospital facilities. 

"We are so grateful for the leadership Mr. Munger demonstrates daily.  This gift is a marvelous acknowledgement of his commitment to our patients, physicians, staff, volunteers, and to the Good Samaritan Hospital community in Los Angeles," said Andrew B. Leeka, president and CEO of Good Samaritan Hospital. 

According to Mr. Munger, "Those of us who have been very fortunate have a duty to give back."  Mr. Munger focuses his philanthropic efforts on three or four public causes that are important to him and where he feels he can make the greatest impact.

The emergency department project will include the expansion of the waiting area and increase the number of patient beds from 12 to 24 beds.  This expansion will ensure that Good Samaritan Hospital remains at the forefront of providing quality health care services for the people of Los Angeles.    

First opened in 1885, Good Samaritan Hospital is a 408-bed tertiary care facility offering some of the most comprehensive care in Los Angeles.  Specializing in cardiac, orthopaedic, oncologic, ophthalmologic, and women's services, Good Samaritan Hospital offers various medical and surgical programs in its six centers of excellence: Heart & Vascular Center, Comprehensive Orthopaedic Center, Davajan-Cabal Center for Perinatal Medicine, Pancreatico-Biliary, Tertiary Retinal Surgery, and Transfusion-Free Medicine & Surgery Center.  For more information visit www.goodsam.org.

SOURCE Good Samaritan Hospital, Los Angeles


These press releases may also interest you

at 08:50
Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, today announced positive topline results from its Phase 1b clinical trial evaluating the safety and efficacy of...

at 08:47
Dr. Mary C. McCluskey, psychotherapist, and author revitalizes Dr. Alfred Adler, the "Pioneer in the Prevention of Mental Health Disorders" and Dr. Pierre Janet "Father of Trauma Treatment Theory" using a time-traveling hot air balloon to create a...

at 08:45
The "Peptide Synthesis: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of...

at 08:45
Ligand Pharmaceuticals Incorporated today announced that it will report first quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, May 7, 2024, and will hold a conference call at 4:30 p.m. Eastern Time that same...

at 08:45
The National Foundation for Infectious Diseases (NFID) and technology company Fraym are partnering on a pilot project to deliver novel, hyperlocal insights to empower public health stakeholders working to increase vaccine uptake across the US....

at 08:44
BioPhotas Inc., manufacturers of the award-winning Celluma SERIES of light therapy devices, recently welcomed Annet King as its new Vice President of Global Sales. Annet has more than 25 years of clinical education and sales management experience and...



News published on and distributed by: